ArticleInternational journal of biological sciences2018

A dual-specific IGF-I/II human engineered antibody domain inhibits IGF signaling in breast cancer cells.

Zhizhen Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.